| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.2 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.2 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.2 |